UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

Securities to be registered pursuant to Section 12(b) of the Act:

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box   ☐

If this form relates to the registration of a class of securities pursuant to Section 12 (g) of the Exchange Act and is effective pursuant to General Instructions A.(d), check the following box   ☒

Securities Act registration statement file number to which this form relates: 333- - 209744

Securities to be registered pursuant to Section 12(g) of the Act:

Ordinary Shares, with a par value of NIS 0.01 per share

INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 1.   Description of Registrant’s Securities to be Registered

A description of the Registrant’s Ordinary Shares is set forth under the caption “Additional Information” contained in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on May 15, 2018 (the “Form 20-F”), and is set forth under the caption “Description of Share Capital” in the prospectus included in the Company’s Registration Statement on Form F-1 (File No. 333-209744) as filed with the Securities and Exchange Commission on July 27, 2016 (the “Registration Statement”), which descriptions are hereby incorporated by reference to the prior filings in response to this item. 

Item 2.   Exhibits

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Act of 1934, the registrant has duly caused this registration statement on its behalf by the undersigned, thereto duly authorized.

TODOS MEDICAL LTD.

February 14, 2019